vs
BayFirst Financial Corp.（BAFN）与C4 Therapeutics, Inc.（CCCC）财务数据对比。点击上方公司名可切换其他公司
C4 Therapeutics, Inc.的季度营收约是BayFirst Financial Corp.的1.1倍（$11.0M vs $10.3M），BayFirst Financial Corp.净利率更高（-55.0% vs -186.0%，领先131.0%），过去两年C4 Therapeutics, Inc.的营收复合增速更高（90.4% vs -29.6%）
PNC金融服务集团是一家总部位于美国宾夕法尼亚州匹兹堡的银行控股金融服务企业。旗下核心子公司PNC银行在美国27个州及华盛顿哥伦比亚特区开展业务，拥有超2600家分支机构和近9500台ATM，按资产、网点数量、存款规模及ATM数量计算，是美国规模名列前茅的大型银行。
C4 Therapeutics是一家临床阶段生物制药企业，专注于开发靶向蛋白降解疗法，用于治疗癌症及其他存在重大未满足医疗需求的严重疾病。公司依托自有专利TORPEDO平台设计小分子降解剂清除致病蛋白，目前拥有多条肿瘤领域研发管线，并与头部制药企业达成战略合作。
BAFN vs CCCC — 直观对比
营收规模更大
CCCC
是对方的1.1倍
$10.3M
净利率更高
BAFN
高出131.0%
-186.0%
两年增速更快
CCCC
近两年复合增速
-29.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.3M | $11.0M |
| 净利润 | $-5.7M | $-20.5M |
| 毛利率 | — | — |
| 营业利润率 | — | -210.1% |
| 净利率 | -55.0% | -186.0% |
| 营收同比 | — | 112.8% |
| 净利润同比 | -130.6% | 40.7% |
| 每股收益（稀释后） | $-1.48 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BAFNCCCC
| Q1 26 | $10.3M | — | ||
| Q4 25 | $11.2M | $11.0M | ||
| Q3 25 | $10.2M | $11.2M | ||
| Q2 25 | $23.1M | $6.5M | ||
| Q1 25 | $19.8M | $7.2M | ||
| Q4 24 | $32.9M | $5.2M | ||
| Q3 24 | $21.7M | $15.4M | ||
| Q2 24 | $20.8M | $12.0M |
净利润BAFNCCCC
| Q1 26 | $-5.7M | — | ||
| Q4 25 | $-2.5M | $-20.5M | ||
| Q3 25 | $-18.9M | $-32.2M | ||
| Q2 25 | $-1.2M | $-26.0M | ||
| Q1 25 | $-335.0K | $-26.3M | ||
| Q4 24 | $9.8M | $-34.6M | ||
| Q3 24 | $1.1M | $-24.7M | ||
| Q2 24 | $866.0K | $-17.7M |
营业利润率BAFNCCCC
| Q1 26 | — | — | ||
| Q4 25 | -25.3% | -210.1% | ||
| Q3 25 | -253.0% | -306.4% | ||
| Q2 25 | -7.1% | -441.0% | ||
| Q1 25 | -2.3% | -402.9% | ||
| Q4 24 | — | -728.4% | ||
| Q3 24 | 7.1% | -183.9% | ||
| Q2 24 | 5.9% | -178.6% |
净利率BAFNCCCC
| Q1 26 | -55.0% | — | ||
| Q4 25 | -22.1% | -186.0% | ||
| Q3 25 | -184.7% | -286.4% | ||
| Q2 25 | -5.3% | -402.6% | ||
| Q1 25 | -1.7% | -363.7% | ||
| Q4 24 | 91.8% | -667.8% | ||
| Q3 24 | 5.2% | -160.6% | ||
| Q2 24 | 4.2% | -147.6% |
每股收益（稀释后）BAFNCCCC
| Q1 26 | $-1.48 | — | ||
| Q4 25 | $-0.71 | $-0.09 | ||
| Q3 25 | $-4.66 | $-0.44 | ||
| Q2 25 | $-0.39 | $-0.37 | ||
| Q1 25 | $-0.17 | $-0.37 | ||
| Q4 24 | $2.21 | $-0.50 | ||
| Q3 24 | $0.18 | $-0.35 | ||
| Q2 24 | $0.12 | $-0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $134.5M | $74.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $81.9M | $256.6M |
| 总资产 | $1.2B | $359.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BAFNCCCC
| Q1 26 | $134.5M | — | ||
| Q4 25 | $207.0M | $74.6M | ||
| Q3 25 | $118.5M | $58.8M | ||
| Q2 25 | $77.3M | $78.2M | ||
| Q1 25 | $63.2M | $51.3M | ||
| Q4 24 | $77.8M | $55.5M | ||
| Q3 24 | $64.4M | $59.6M | ||
| Q2 24 | $60.8M | $73.1M |
股东权益BAFNCCCC
| Q1 26 | $81.9M | — | ||
| Q4 25 | $87.6M | $256.6M | ||
| Q3 25 | $89.7M | $154.4M | ||
| Q2 25 | $108.2M | $174.1M | ||
| Q1 25 | $110.1M | $195.1M | ||
| Q4 24 | $110.9M | $216.0M | ||
| Q3 24 | $102.3M | $242.7M | ||
| Q2 24 | $101.0M | $247.1M |
总资产BAFNCCCC
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.3B | $359.1M | ||
| Q3 25 | $1.3B | $265.5M | ||
| Q2 25 | $1.3B | $296.5M | ||
| Q1 25 | $1.3B | $319.5M | ||
| Q4 24 | $1.3B | $349.6M | ||
| Q3 24 | $1.2B | $376.1M | ||
| Q2 24 | $1.2B | $381.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-22.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BAFNCCCC
| Q1 26 | — | — | ||
| Q4 25 | $285.3M | $-22.1M | ||
| Q3 25 | $47.3M | $-31.2M | ||
| Q2 25 | $63.3M | $-12.1M | ||
| Q1 25 | $74.2M | $-33.3M | ||
| Q4 24 | $390.5M | $-17.9M | ||
| Q3 24 | $90.8M | $-24.1M | ||
| Q2 24 | $78.8M | $-5.0M |
自由现金流BAFNCCCC
| Q1 26 | — | — | ||
| Q4 25 | $285.0M | — | ||
| Q3 25 | $47.3M | $-31.6M | ||
| Q2 25 | $63.1M | — | ||
| Q1 25 | $74.1M | — | ||
| Q4 24 | $388.8M | $-17.9M | ||
| Q3 24 | $90.5M | $-24.1M | ||
| Q2 24 | $78.4M | $-5.2M |
自由现金流率BAFNCCCC
| Q1 26 | — | — | ||
| Q4 25 | 2554.2% | — | ||
| Q3 25 | 462.2% | -281.5% | ||
| Q2 25 | 272.7% | — | ||
| Q1 25 | 375.1% | — | ||
| Q4 24 | 1180.9% | -346.5% | ||
| Q3 24 | 416.5% | -157.2% | ||
| Q2 24 | 376.1% | -43.1% |
资本支出强度BAFNCCCC
| Q1 26 | — | — | ||
| Q4 25 | 2.7% | — | ||
| Q3 25 | 0.1% | 3.7% | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 5.1% | 0.1% | ||
| Q3 24 | 1.5% | 0.1% | ||
| Q2 24 | 1.9% | 1.6% |
现金转化率BAFNCCCC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 39.95× | — | ||
| Q3 24 | 79.85× | — | ||
| Q2 24 | 90.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BAFN
| Net Interest Income | $9.4M | 91% |
| Noninterest Income | $884.0K | 9% |
CCCC
暂无分部数据
